BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36849151)

  • 21.
    Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
    Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
    [No Abstract]   [Full Text] [Related]  

  • 22. Spectrum of mutations in the
    Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
    Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
    Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
    Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
    Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of RB1 in human embryonic stem cell-derived retinal organoids.
    Zheng C; Schneider JW; Hsieh J
    Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis.
    Jiménez I; Laé M; Tanguy ML; Savignoni A; Gauthier-Villars M; Desjardins L; Cassoux N; Dendale R; Rodriguez J; Doz F; Brisse HJ; Aerts I
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28158. PubMed ID: 31904159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal versus Postnatal Screening for Familial Retinoblastoma.
    Soliman SE; Dimaras H; Khetan V; Gardiner JA; Chan HS; Héon E; Gallie BL
    Ophthalmology; 2016 Dec; 123(12):2610-2617. PubMed ID: 27712844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
    Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Ahmed RM; Denman M; Steele CD; Tarabichi M; Roy E; Davies LR; Manji J; Cristalli C; Scotlandi K; Pillay N; Strauss SJ; Mittnacht S
    Nat Commun; 2021 Dec; 12(1):7064. PubMed ID: 34862364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifocal osteosarcoma as second tumor after childhood retinoblastoma.
    Potepan P; Luksch R; Sozzi G; Testi A; Laffranchi A; Danesini GM; Parafioriti A; Giardini R; Spagnoli I
    Skeletal Radiol; 1999 Jul; 28(7):415-21. PubMed ID: 10478625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple malignancies in a patient with bilateral retinoblastoma.
    Ceha HM; Balm AJ; de Jong D; van 't Veer LJ
    J Laryngol Otol; 1998 Feb; 112(2):189-92. PubMed ID: 9578885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel germline mutation in the RB1 gene with multifocal bone tumors following retinoblastoma.
    Matsumoto H; Kobayashi O; Tamura K; Sekine I; Yamamoto M
    Pediatr Int; 2003 Dec; 45(6):728-30. PubMed ID: 14651550
    [No Abstract]   [Full Text] [Related]  

  • 33. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mature Ovarian Teratoma After Treatment for Unilateral Retinoblastoma With Nonmutated RB1.
    Collins B; Corey SJ
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):485-486. PubMed ID: 28719514
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
    Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
    Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiation-induced osteosarcoma after bilateral childhood retinoblastoma.
    Chan LL; Czerniak BA; Ginsberg LE
    AJR Am J Roentgenol; 2000 May; 174(5):1288. PubMed ID: 10789778
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous identification of clinically relevant
    Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
    Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral retinoblastoma with one eye manifesting only posterior chamber infiltration and no retinal involvement.
    Ossandon D; Kastner A; Zanolli M; Solanes F; Pérez V; Repetto G; Benavides F; Shields CL
    J AAPOS; 2016 Dec; 20(6):548-550.e1. PubMed ID: 27815188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
    Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
    Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.